echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Gale and Suzhou Corning Jerry signed a global exclusive development agreement for ASC22 (Envolimab) for the treatment of hepatitis B and other viral diseases

    Gale and Suzhou Corning Jerry signed a global exclusive development agreement for ASC22 (Envolimab) for the treatment of hepatitis B and other viral diseases

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hangzhou, Shaoxing, and Suzhou, China, November 8, 2021/PRNewswire/ ---Gallery Pharmaceutical Co.


    Under the terms of the agreement, Corning Jerry Suzhou song ceremony to grant the development and commercialization ASC22 outside Greater China exclusive worldwide rights, authorized indications for all viral diseases, including hepatitis B, including


    Together with the exclusive development agreement for Greater China jointly announced by Songli and Suzhou Corning Jerry on January 14, 2019 (see press release for details: https:// Suzhou Jerry Corning has been granted for the treatment of the song ceremony ASC22 exclusive worldwide development and commercialization rights and interests of all viral diseases, including hepatitis B, including


    ASC22 is an immunotherapy with the fastest progress in clinical research and development in the world by blocking the PD-1/PD-L1 signaling pathway for the functional cure of chronic hepatitis B (ie, the disappearance of hepatitis B surface antigen)


    ASC22 is currently undergoing a phase IIb clinical trial in China.


    Dr.


    About songli

    Gale is an innovative R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.


    1.


    Source: Golly Pharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.